WHS Findings Back Expanded Aspirin Professional Labeling – Bayer
This article was originally published in The Tan Sheet
Executive Summary
Results from the Women's Health Study showing the effects of aspirin therapy in women support Bayer Consumer Care's citizen petition requesting expanded professional labeling, the firm says
You may also be interested in...
CHARISMA May Make Bayer Primary MI Prevention Petition More Popular
Bayer's bid for an indication for the primary prevention of MI on professional aspirin labeling may be strengthened by data from the CHARISMA trial
Aspirin Therapy Lowers Stroke Risk In Women, MI Risk In Men – JAMA
A recent meta-analysis identifying aspirin's cardiovascular benefits as gender-specific may demonstrate that primary prevention benefits extend to low-risk groups
Aspirin MI Primary Prevention Labeling Urged In Bayer Citizen Petition
Aspirin therapy led to a statistically significant 32% reduction in first myocardial infarctions among over 55,000 subjects evaluated in a meta-analysis of five primary prevention studies conducted by Bayer Consumer Care